Barrington Research Reiterates “Outperform” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reaffirmed by equities researchers at Barrington Research in a research report issued on Wednesday,Benzinga reports. They currently have a $18.00 price target on the medical instruments supplier’s stock. Barrington Research’s target price points to a potential upside of 42.97% from the company’s current price.

Other research analysts have also issued research reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a research note on Friday, August 8th. Finally, UBS Group cut their price target on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research note on Tuesday. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $17.91.

DENTSPLY SIRONA Stock Down 2.1%

DENTSPLY SIRONA stock opened at $12.59 on Wednesday. The company’s 50 day simple moving average is $13.26 and its 200 day simple moving average is $14.50. DENTSPLY SIRONA has a fifty-two week low of $11.69 and a fifty-two week high of $24.86. The firm has a market capitalization of $2.51 billion, a price-to-earnings ratio of -2.66, a PEG ratio of 0.81 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter last year, the firm earned $0.49 EPS. DENTSPLY SIRONA’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, sell-side analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. AQR Capital Management LLC raised its holdings in shares of DENTSPLY SIRONA by 109.8% in the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the last quarter. Norges Bank acquired a new stake in shares of DENTSPLY SIRONA in the second quarter valued at approximately $39,700,000. Goldman Sachs Group Inc. raised its holdings in shares of DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after purchasing an additional 2,172,343 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the last quarter. Finally, Ninety One UK Ltd acquired a new position in DENTSPLY SIRONA during the second quarter worth $18,418,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.